RT Generic
T1 Conservative Treatment of Ankle Osteoarthritis
A1 Tejero, Sergio
A1 Prada-Chamorro, Estefania
A1 Gonzalez-Martin, David
A1 Garcia-Guirao, Antonio
A1 Galhoum, Ahmed
A1 Valderrabano, Victor
A1 Herrera-Perez, Mario
K1 conservative treatment ankle osteoarthritis
K1 viscosupplementation
K1 platelet-rich plasma
K1 mesenchymal stem cells
K1 biologics
K1 Platelet-rich plasma
K1 Intraarticular injection
K1 Follow-up
K1 Hyaluronate
K1 Arthritis
K1 Efficacy
K1 Safety
K1 Foot
K1 Knee
AB Despite the disabling nature of ankle osteoarthritis (OA), there is poor scientific evidence for a conservative treatment compared to the hip and knee OA. In this regard, most of the treatment options in use are not based on clinical studies of the ankle, and they are extracted from evidence obtained from clinical studies of other lower limb joints. However, this does not seem to be a good idea, since the aetiology of ankle OA is quite different from that of the hip or knee. Nonpharmacological and pharmacological treatments such as nonsteroidal anti-inflammatory drugs, hyaluronic acid, corticosteroid, platelet-rich plasma injection and mesenchymal stem cells injections have been reported. However, further research is required in this field to obtain a specific clinical practice guideline for the conservative treatment of ankle OA.
PB Mdpi
YR 2021
FD 2021-10-01
LK https://hdl.handle.net/10668/27359
UL https://hdl.handle.net/10668/27359
LA en
DS RISalud
RD Apr 5, 2025